RETA Reata Pharma: Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan

Simbol resmi perusahaan Reata Pharmaceuticals, Inc. (RETA)

Insurance bureaucracy and the launch costs of Skyclarys are putting pressure on revenues for Reata Pharmaceuticals (RETA). The quarterly EPS growth trend clearly demonstrates the actual profitability per share, where the parameter value equals 0.00. A monopoly status in the treatment of Friedreich's ataxia provides Reata Pharmaceuticals (RETA) with pricing power, while the implementation of ESG standards in laboratories minimizes harmful emissions.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Reata Pharmaceuticals, Inc. (RETA): kanggo periode 04.07.2022 - 07.10.2023

Rincian analitis perusahaan Reata Pharmaceuticals

Analisis fundamental perusahaan:reatapharma.com, RETA
Produk asil prodhuksi Reata Pharma

This indicator measures the quarterly dynamics of earnings per share, allowing for an assessment of whether operational efficiency is outpacing cost inflation and rising expenses. By analyzing the current level of quarterly EPS growth, an investor can see Reata Pharmaceuticals (RETA) exercising unrestricted pricing power as a monopolist in Friedreich's ataxia therapy, which converts directly into exceptional business margins.

Analisis perusahaan pesaing

JAZZ (Jazz Pharmaceuticals PLC) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cytokinetics Corp (CYTK) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan PTC Therapeutics, Inc.|SRRK: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Centessa Corp (CNTA)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan DYN (Dyne Therapeutics Inc)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Edgewise Pharma EWTX|Rapport Corp - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ALMS - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Zevra Therapeutics|CTNM: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Larimar Pharma LRMR|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan CAPR|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Entrada TRDA|Wutah bathi EPS kuartalan PTHS|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan MediciNova MNOV|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Serina Therapeutics SER|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan BioXcel Therapeutics Inc (BTAI)|PMN - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Apimeds Pharmaceuticals US APUS|AEON Biopharma (AEON) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NLS Pharma - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Bionomics Ltd.|FSD Pharma - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan